CN Stock MarketDetailed Quotes

003020 Hefei Lifeon Pharmaceutical

Watchlist
  • 19.56
  • -0.34-1.71%
Market Closed Dec 13 15:00 CST
3.75BMarket Cap21.49P/E (TTM)

Hefei Lifeon Pharmaceutical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(Q9)Sep 30, 2024
(Q6)Jun 30, 2024
(Q3)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
(Q6)Jun 30, 2022
Assets
Current assets
Money funds
57.76%319.78M
13.20%267.77M
-36.62%187.75M
-21.73%502.93M
-37.38%202.71M
-13.19%236.54M
64.49%296.24M
-1.78%642.58M
31.89%323.72M
56.30%272.48M
Transactional financial assets
-37.01%167.86M
-51.64%157.9M
3.99%322.49M
53,216.45%61.52M
-21.84%266.48M
-18.90%326.49M
-29.54%310.11M
-12.95%115.39K
-15.03%340.96M
-15.48%402.56M
Notes receivable and accounts receivable
50.97%357.15M
87.20%354.61M
-39.37%282.39M
-19.25%259.24M
-48.66%236.56M
-48.54%189.43M
3.42%465.77M
0.90%321.02M
8.46%460.81M
8.73%368.13M
-Notes receivable
----
----
--200K
700.00%792K
--807.5K
----
----
-99.72%99K
----
--0
-Accounts receivable
51.49%357.15M
87.20%354.61M
-39.41%282.19M
-19.47%258.45M
-48.84%235.75M
-48.54%189.43M
12.12%465.77M
13.54%320.92M
18.07%460.81M
16.64%368.13M
Other receivables (including interest and dividends)
-62.35%15.34M
-80.16%14.69M
111.68%20.72M
361.29%19.97M
695.97%40.73M
1,127.34%74.04M
25.57%9.79M
-28.80%4.33M
18.08%5.12M
75.86%6.03M
-Dividend receivable
----
----
--4.96M
--4.96M
--34.96M
--69.31M
----
----
----
----
-Accrued interest receivable
----
----
----
----
----
--0
----
----
----
----
-Other receivable
----
210.69%14.69M
----
----
----
-21.62%4.73M
----
-28.80%4.33M
----
75.86%6.03M
Advance payment
1.48%24.59M
21.56%22.22M
-13.38%43.07M
-88.46%9.36M
-47.55%24.23M
-74.07%18.28M
5.48%49.72M
57.55%81.07M
-14.65%46.21M
103.23%70.51M
Inventories
-18.87%209.91M
27.60%220.41M
-38.04%231.14M
-32.85%242.91M
-19.50%258.72M
-34.75%172.74M
36.33%373.04M
91.55%361.76M
47.45%321.4M
20.68%264.73M
Receivable financing
71.40%45.22M
-15.88%33.28M
-22.18%30.41M
13.39%35.95M
-20.46%26.38M
7.91%39.57M
57.21%39.08M
15,851.35%31.7M
478.88%33.17M
2,205.22%36.67M
Other current assets
3.53%18.16M
29.91%20.31M
64.65%21.89M
93.43%19.26M
274.46%17.55M
933.77%15.63M
1,009.05%13.29M
1,913.84%9.96M
470.68%4.69M
-16.38%1.51M
Total current assets
7.89%1.16B
1.72%1.09B
-26.79%1.14B
-20.75%1.15B
-30.12%1.07B
-24.60%1.07B
9.25%1.56B
19.10%1.45B
13.40%1.54B
13.80%1.42B
Non Current assets
Other equity investment
1,250.75%19.44M
--16.44M
--16.44M
--16.44M
--1.44M
----
----
--0
----
----
Investment real estate
-24.11%25.03M
-11.40%25.22M
5.71%25.42M
858.94%25.62M
1,087.85%32.98M
888.13%28.47M
705.29%24.05M
-13.58%2.67M
-13.13%2.78M
-12.72%2.88M
Long-term equity investment
12.10%176.06M
7.53%169.62M
287.79%169.6M
1,038.71%163.95M
939.46%157.05M
743.12%157.75M
126.99%43.74M
-30.47%14.4M
-15.46%15.11M
-1.84%18.71M
Fixed assets
----
284.65%587.73M
----
----
----
-10.18%152.8M
----
28.54%182.38M
----
16.51%170.12M
Constru in process
----
-21.65%333.44M
----
----
----
112.62%425.59M
----
161.52%340.89M
----
158.88%200.17M
Productive biological assets
0.59%2.42M
--2.42M
--2.41M
--2.4M
--2.4M
----
----
----
----
----
Intangible assets
5.16%106.87M
43.41%109M
34.57%110.96M
35.86%113.29M
20.22%101.63M
-11.49%76.01M
-6.26%82.45M
-6.84%83.38M
-6.69%84.54M
121.15%85.88M
Development expenditure
16.35%2.5M
84.66%2.59M
173.39%2.82M
50.39%2.08M
94.99%2.15M
90.38%1.4M
40.46%1.03M
88.42%1.39M
164.08%1.1M
--735.6K
Goodwill
1.24%74.44M
--74.44M
--74.44M
--74.44M
--73.53M
----
----
----
----
----
Long deferred expense
-19.95%4.37M
-5.16%4.95M
-0.02%5.71M
-14.51%5.32M
-17.15%5.46M
-26.91%5.21M
-24.13%5.71M
-22.72%6.23M
-17.63%6.6M
-12.80%7.13M
Deferred tax assets
50.06%18.49M
22.76%15.88M
45.16%15.73M
88.00%16.13M
64.93%12.32M
82.78%12.94M
79.14%10.84M
46.42%8.58M
80.40%7.47M
49.79%7.08M
Usufruct assets
8.08%11.41M
16.52%12.82M
-38.17%8.1M
-37.37%9.3M
-47.57%10.56M
-48.87%11M
-47.17%13.09M
-44.58%14.85M
-36.66%20.13M
-34.09%21.52M
Other non current assets
33.06%22.33M
146.69%38.15M
85.93%21.98M
18.14%16.64M
-28.08%16.78M
-39.02%15.46M
-74.14%11.82M
-49.34%14.09M
-17.15%23.33M
-24.53%25.36M
Total non current assets
22.12%1.4B
57.08%1.39B
80.85%1.35B
99.23%1.33B
94.10%1.14B
64.32%886.64M
57.76%748.98M
47.07%668.85M
41.78%589.27M
48.36%539.59M
Total assets
15.23%2.55B
26.77%2.48B
8.17%2.49B
17.08%2.48B
4.32%2.22B
-0.15%1.96B
21.37%2.31B
26.69%2.12B
20.06%2.13B
21.59%1.96B
Liabilities
Current liabilities
Short term loan
----
----
----
----
----
----
--41.99M
----
----
----
Notes payable and accounts payable
13.12%328.12M
44.99%340.44M
-43.57%308.24M
-34.60%301.25M
-45.57%290.07M
-51.76%234.8M
23.93%546.25M
89.63%460.66M
30.73%532.94M
61.62%486.77M
-Notes payable
----
----
----
----
----
----
5.31%194.01M
128.15%213.72M
55.78%183.62M
82.62%235.1M
-Accounts payable
13.12%328.12M
44.99%340.44M
-12.49%308.24M
22.00%301.25M
-16.96%290.07M
-6.70%234.8M
37.29%352.24M
65.45%246.94M
20.55%349.33M
45.95%251.67M
Contract liabilities
-19.12%15.57M
-32.56%11.92M
-22.30%16.35M
-74.87%10.71M
26.82%19.25M
2.57%17.67M
23.78%21.04M
190.08%42.62M
31.83%15.18M
47.84%17.23M
Advance receipts
----
----
----
--276.4K
----
--258.93K
----
----
----
----
Salaries payable
18.64%29.09M
6.18%22.91M
12.71%18.83M
23.19%32.38M
10.96%24.52M
34.09%21.57M
19.44%16.71M
5.50%26.28M
22.79%22.09M
14.15%16.09M
Taxs payable
67.69%34.78M
31.45%39.25M
-30.76%28M
29.82%35.94M
-25.13%20.74M
60.22%29.86M
106.28%40.43M
-6.63%27.68M
78.54%27.7M
61.69%18.64M
Other payable (including interest and dividends)
63.52%121.2M
82.67%117.28M
154.34%142.02M
214.26%156.41M
49.46%74.12M
192.63%64.2M
260.50%55.84M
252.92%49.77M
233.76%49.59M
61.91%21.94M
-Dividend payable
----
----
--15.68M
--15.68M
----
----
----
----
----
----
-Other payable
----
82.67%117.28M
----
----
----
192.63%64.2M
----
252.92%49.77M
----
61.91%21.94M
Non current liabilities due within one year
34.00%7.18M
8.00%5.34M
-48.52%4.93M
-54.77%4.54M
--5.36M
-34.80%4.94M
--9.59M
--10.03M
----
--7.58M
Other current liabilities
-33.51%1.86M
-34.99%1.45M
-53.38%1.99M
-78.00%1.23M
49.70%2.8M
5.36%2.23M
102.13%4.28M
215.66%5.59M
36.72%1.87M
47.90%2.12M
Total current liabilities
23.11%537.8M
43.41%538.58M
-29.31%520.37M
-12.83%542.73M
-32.73%436.86M
-34.16%375.54M
44.63%736.12M
89.79%622.63M
38.49%649.38M
61.38%570.36M
Current liabilities
Long term loan
--59.65M
--31.03M
--31M
--31.01M
----
----
----
----
----
----
Long term account payable
----
----
----
----
----
--0
----
--0
----
--0
Specific account payable
----
----
----
----
----
-96.13%1.16M
----
-75.11%1.16M
----
310.40%29.96M
Deferred tax liabilities
11.45%12.32M
164.25%11.31M
824.34%13.14M
868.11%13.43M
8,236.25%11.06M
985.30%4.28M
788.81%1.42M
--1.39M
-14.65%132.62K
101.78%394.37K
Long term deferred income
29.87%18.27M
57.90%18.92M
57.56%19.67M
55.35%20.16M
4.39%14.07M
-1.37%11.98M
-2.32%12.48M
-1.95%12.98M
20.75%13.48M
4.80%12.15M
Lease liabilities
-32.83%2.12M
13.88%5.12M
-32.68%1.38M
-15.91%2.84M
-82.95%3.16M
-62.90%4.5M
-90.85%2.05M
-86.25%3.38M
-37.53%18.52M
-59.61%12.12M
Total non current liabilities
213.70%92.36M
202.82%66.38M
280.97%65.18M
256.77%67.45M
-52.58%29.44M
-59.87%21.92M
-57.18%17.11M
-55.49%18.91M
28.64%62.09M
11.25%54.62M
Total liabilities
35.14%630.16M
52.21%604.96M
-22.26%585.55M
-4.89%610.18M
-34.46%466.3M
-36.40%397.46M
37.22%753.23M
73.14%641.53M
37.57%711.47M
55.26%624.99M
Shareholders equity
Paid-in capital
19.98%191.57M
20.33%191.57M
30.36%159.64M
30.38%159.68M
30.38%159.68M
32.20%159.21M
32.20%122.47M
32.20%122.47M
32.20%122.47M
30.00%120.43M
Capital reserve funds
-1.75%530.91M
-0.19%528.94M
-1.07%555.36M
-0.55%551.89M
2.41%540.36M
6.34%529.96M
6.69%561.36M
5.47%554.93M
1.05%527.64M
-4.55%498.37M
Surplus reserve funds
25.14%81.98M
27.63%81.98M
29.36%81.98M
29.36%81.98M
35.18%65.51M
32.55%64.23M
30.77%63.37M
30.77%63.37M
0.76%48.46M
0.76%48.46M
Retained profit
8.85%947.9M
8.98%910.58M
12.73%938.61M
19.17%912.97M
17.31%870.86M
24.71%835.53M
21.77%832.63M
20.34%766.13M
25.79%742.35M
22.17%669.97M
Less:Treasury stock
-34.73%20.66M
-23.62%20.66M
-23.62%20.66M
-22.41%20.99M
17.03%31.65M
--27.05M
--27.05M
--27.05M
--27.05M
----
Shareholders equity without minority interests
7.91%1.73B
8.36%1.69B
10.44%1.71B
13.90%1.69B
13.50%1.6B
16.80%1.56B
14.93%1.55B
13.49%1.48B
12.84%1.41B
10.40%1.34B
Minority interests
32.07%192.96M
--186.54M
--193.9M
--187.97M
--146.1M
----
----
----
----
----
Total shareholder equity
9.93%1.92B
20.30%1.88B
22.93%1.91B
26.60%1.87B
23.83%1.75B
16.80%1.56B
14.93%1.55B
13.49%1.48B
12.84%1.41B
10.40%1.34B
Total liabilityies and equity
15.23%2.55B
26.77%2.48B
8.17%2.49B
17.08%2.48B
4.32%2.22B
-0.15%1.96B
21.37%2.31B
26.69%2.12B
20.06%2.13B
21.59%1.96B
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
--
--
Unqualified opinion
--
--
--
Unqualified opinion
--
--
Auditor
--
--
--
Zhonghui Certified Public Accountants (Special General Partnership)
--
--
--
Zhonghui Certified Public Accountants (Special General Partnership)
--
--
(Q9)Sep 30, 2024(Q6)Jun 30, 2024(Q3)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022(Q6)Jun 30, 2022
Assets
Current assets
Money funds 57.76%319.78M13.20%267.77M-36.62%187.75M-21.73%502.93M-37.38%202.71M-13.19%236.54M64.49%296.24M-1.78%642.58M31.89%323.72M56.30%272.48M
Transactional financial assets -37.01%167.86M-51.64%157.9M3.99%322.49M53,216.45%61.52M-21.84%266.48M-18.90%326.49M-29.54%310.11M-12.95%115.39K-15.03%340.96M-15.48%402.56M
Notes receivable and accounts receivable 50.97%357.15M87.20%354.61M-39.37%282.39M-19.25%259.24M-48.66%236.56M-48.54%189.43M3.42%465.77M0.90%321.02M8.46%460.81M8.73%368.13M
-Notes receivable ----------200K700.00%792K--807.5K---------99.72%99K------0
-Accounts receivable 51.49%357.15M87.20%354.61M-39.41%282.19M-19.47%258.45M-48.84%235.75M-48.54%189.43M12.12%465.77M13.54%320.92M18.07%460.81M16.64%368.13M
Other receivables (including interest and dividends) -62.35%15.34M-80.16%14.69M111.68%20.72M361.29%19.97M695.97%40.73M1,127.34%74.04M25.57%9.79M-28.80%4.33M18.08%5.12M75.86%6.03M
-Dividend receivable ----------4.96M--4.96M--34.96M--69.31M----------------
-Accrued interest receivable ----------------------0----------------
-Other receivable ----210.69%14.69M-------------21.62%4.73M-----28.80%4.33M----75.86%6.03M
Advance payment 1.48%24.59M21.56%22.22M-13.38%43.07M-88.46%9.36M-47.55%24.23M-74.07%18.28M5.48%49.72M57.55%81.07M-14.65%46.21M103.23%70.51M
Inventories -18.87%209.91M27.60%220.41M-38.04%231.14M-32.85%242.91M-19.50%258.72M-34.75%172.74M36.33%373.04M91.55%361.76M47.45%321.4M20.68%264.73M
Receivable financing 71.40%45.22M-15.88%33.28M-22.18%30.41M13.39%35.95M-20.46%26.38M7.91%39.57M57.21%39.08M15,851.35%31.7M478.88%33.17M2,205.22%36.67M
Other current assets 3.53%18.16M29.91%20.31M64.65%21.89M93.43%19.26M274.46%17.55M933.77%15.63M1,009.05%13.29M1,913.84%9.96M470.68%4.69M-16.38%1.51M
Total current assets 7.89%1.16B1.72%1.09B-26.79%1.14B-20.75%1.15B-30.12%1.07B-24.60%1.07B9.25%1.56B19.10%1.45B13.40%1.54B13.80%1.42B
Non Current assets
Other equity investment 1,250.75%19.44M--16.44M--16.44M--16.44M--1.44M----------0--------
Investment real estate -24.11%25.03M-11.40%25.22M5.71%25.42M858.94%25.62M1,087.85%32.98M888.13%28.47M705.29%24.05M-13.58%2.67M-13.13%2.78M-12.72%2.88M
Long-term equity investment 12.10%176.06M7.53%169.62M287.79%169.6M1,038.71%163.95M939.46%157.05M743.12%157.75M126.99%43.74M-30.47%14.4M-15.46%15.11M-1.84%18.71M
Fixed assets ----284.65%587.73M-------------10.18%152.8M----28.54%182.38M----16.51%170.12M
Constru in process -----21.65%333.44M------------112.62%425.59M----161.52%340.89M----158.88%200.17M
Productive biological assets 0.59%2.42M--2.42M--2.41M--2.4M--2.4M--------------------
Intangible assets 5.16%106.87M43.41%109M34.57%110.96M35.86%113.29M20.22%101.63M-11.49%76.01M-6.26%82.45M-6.84%83.38M-6.69%84.54M121.15%85.88M
Development expenditure 16.35%2.5M84.66%2.59M173.39%2.82M50.39%2.08M94.99%2.15M90.38%1.4M40.46%1.03M88.42%1.39M164.08%1.1M--735.6K
Goodwill 1.24%74.44M--74.44M--74.44M--74.44M--73.53M--------------------
Long deferred expense -19.95%4.37M-5.16%4.95M-0.02%5.71M-14.51%5.32M-17.15%5.46M-26.91%5.21M-24.13%5.71M-22.72%6.23M-17.63%6.6M-12.80%7.13M
Deferred tax assets 50.06%18.49M22.76%15.88M45.16%15.73M88.00%16.13M64.93%12.32M82.78%12.94M79.14%10.84M46.42%8.58M80.40%7.47M49.79%7.08M
Usufruct assets 8.08%11.41M16.52%12.82M-38.17%8.1M-37.37%9.3M-47.57%10.56M-48.87%11M-47.17%13.09M-44.58%14.85M-36.66%20.13M-34.09%21.52M
Other non current assets 33.06%22.33M146.69%38.15M85.93%21.98M18.14%16.64M-28.08%16.78M-39.02%15.46M-74.14%11.82M-49.34%14.09M-17.15%23.33M-24.53%25.36M
Total non current assets 22.12%1.4B57.08%1.39B80.85%1.35B99.23%1.33B94.10%1.14B64.32%886.64M57.76%748.98M47.07%668.85M41.78%589.27M48.36%539.59M
Total assets 15.23%2.55B26.77%2.48B8.17%2.49B17.08%2.48B4.32%2.22B-0.15%1.96B21.37%2.31B26.69%2.12B20.06%2.13B21.59%1.96B
Liabilities
Current liabilities
Short term loan --------------------------41.99M------------
Notes payable and accounts payable 13.12%328.12M44.99%340.44M-43.57%308.24M-34.60%301.25M-45.57%290.07M-51.76%234.8M23.93%546.25M89.63%460.66M30.73%532.94M61.62%486.77M
-Notes payable ------------------------5.31%194.01M128.15%213.72M55.78%183.62M82.62%235.1M
-Accounts payable 13.12%328.12M44.99%340.44M-12.49%308.24M22.00%301.25M-16.96%290.07M-6.70%234.8M37.29%352.24M65.45%246.94M20.55%349.33M45.95%251.67M
Contract liabilities -19.12%15.57M-32.56%11.92M-22.30%16.35M-74.87%10.71M26.82%19.25M2.57%17.67M23.78%21.04M190.08%42.62M31.83%15.18M47.84%17.23M
Advance receipts --------------276.4K------258.93K----------------
Salaries payable 18.64%29.09M6.18%22.91M12.71%18.83M23.19%32.38M10.96%24.52M34.09%21.57M19.44%16.71M5.50%26.28M22.79%22.09M14.15%16.09M
Taxs payable 67.69%34.78M31.45%39.25M-30.76%28M29.82%35.94M-25.13%20.74M60.22%29.86M106.28%40.43M-6.63%27.68M78.54%27.7M61.69%18.64M
Other payable (including interest and dividends) 63.52%121.2M82.67%117.28M154.34%142.02M214.26%156.41M49.46%74.12M192.63%64.2M260.50%55.84M252.92%49.77M233.76%49.59M61.91%21.94M
-Dividend payable ----------15.68M--15.68M------------------------
-Other payable ----82.67%117.28M------------192.63%64.2M----252.92%49.77M----61.91%21.94M
Non current liabilities due within one year 34.00%7.18M8.00%5.34M-48.52%4.93M-54.77%4.54M--5.36M-34.80%4.94M--9.59M--10.03M------7.58M
Other current liabilities -33.51%1.86M-34.99%1.45M-53.38%1.99M-78.00%1.23M49.70%2.8M5.36%2.23M102.13%4.28M215.66%5.59M36.72%1.87M47.90%2.12M
Total current liabilities 23.11%537.8M43.41%538.58M-29.31%520.37M-12.83%542.73M-32.73%436.86M-34.16%375.54M44.63%736.12M89.79%622.63M38.49%649.38M61.38%570.36M
Current liabilities
Long term loan --59.65M--31.03M--31M--31.01M------------------------
Long term account payable ----------------------0------0------0
Specific account payable ---------------------96.13%1.16M-----75.11%1.16M----310.40%29.96M
Deferred tax liabilities 11.45%12.32M164.25%11.31M824.34%13.14M868.11%13.43M8,236.25%11.06M985.30%4.28M788.81%1.42M--1.39M-14.65%132.62K101.78%394.37K
Long term deferred income 29.87%18.27M57.90%18.92M57.56%19.67M55.35%20.16M4.39%14.07M-1.37%11.98M-2.32%12.48M-1.95%12.98M20.75%13.48M4.80%12.15M
Lease liabilities -32.83%2.12M13.88%5.12M-32.68%1.38M-15.91%2.84M-82.95%3.16M-62.90%4.5M-90.85%2.05M-86.25%3.38M-37.53%18.52M-59.61%12.12M
Total non current liabilities 213.70%92.36M202.82%66.38M280.97%65.18M256.77%67.45M-52.58%29.44M-59.87%21.92M-57.18%17.11M-55.49%18.91M28.64%62.09M11.25%54.62M
Total liabilities 35.14%630.16M52.21%604.96M-22.26%585.55M-4.89%610.18M-34.46%466.3M-36.40%397.46M37.22%753.23M73.14%641.53M37.57%711.47M55.26%624.99M
Shareholders equity
Paid-in capital 19.98%191.57M20.33%191.57M30.36%159.64M30.38%159.68M30.38%159.68M32.20%159.21M32.20%122.47M32.20%122.47M32.20%122.47M30.00%120.43M
Capital reserve funds -1.75%530.91M-0.19%528.94M-1.07%555.36M-0.55%551.89M2.41%540.36M6.34%529.96M6.69%561.36M5.47%554.93M1.05%527.64M-4.55%498.37M
Surplus reserve funds 25.14%81.98M27.63%81.98M29.36%81.98M29.36%81.98M35.18%65.51M32.55%64.23M30.77%63.37M30.77%63.37M0.76%48.46M0.76%48.46M
Retained profit 8.85%947.9M8.98%910.58M12.73%938.61M19.17%912.97M17.31%870.86M24.71%835.53M21.77%832.63M20.34%766.13M25.79%742.35M22.17%669.97M
Less:Treasury stock -34.73%20.66M-23.62%20.66M-23.62%20.66M-22.41%20.99M17.03%31.65M--27.05M--27.05M--27.05M--27.05M----
Shareholders equity without minority interests 7.91%1.73B8.36%1.69B10.44%1.71B13.90%1.69B13.50%1.6B16.80%1.56B14.93%1.55B13.49%1.48B12.84%1.41B10.40%1.34B
Minority interests 32.07%192.96M--186.54M--193.9M--187.97M--146.1M--------------------
Total shareholder equity 9.93%1.92B20.30%1.88B22.93%1.91B26.60%1.87B23.83%1.75B16.80%1.56B14.93%1.55B13.49%1.48B12.84%1.41B10.40%1.34B
Total liabilityies and equity 15.23%2.55B26.77%2.48B8.17%2.49B17.08%2.48B4.32%2.22B-0.15%1.96B21.37%2.31B26.69%2.12B20.06%2.13B21.59%1.96B
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions ------Unqualified opinion------Unqualified opinion----
Auditor ------Zhonghui Certified Public Accountants (Special General Partnership)------Zhonghui Certified Public Accountants (Special General Partnership)----

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Heat List
CN
Overall
Symbol
Price
% Chg

No Data

Investment Theme Pharmaceutical E-commerce
Pharmaceutical E-commerce
Intraday-1.88%